Skip to main content
OpenTrials
Completed

NCT Number: NCT02006524

Screening for Silent Atrial Fibrillation During Influenza Vaccination

Silent atrial fibrillation is an important cause of unnecessary strokes. If diagnosed and treated in time with anticoagulants, many disabling strokes can be prevented. In order to improve the diagnosis of atrial fibrillation the MyDiagnostick is developed; a user friendly and easy to use stick that diagnoses atrial fibrillation in one minute. During influenza vaccination, many patients who are also at risk for atrial fibrillation visit the general practice. This offers an ideal opportunity for screening for atrial fibrillation. The study investigates the yield of screening for atrial fibrillation with the MyDiagnostick during influenza vaccination (newly detected atrial fibrillation with corresponding CHA2DS2-Vasc score).

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Eligible for influenza vaccination

Exclusion criteria

  • Not eligible for influenza vaccination

Treatment and study plan

'MyDiagnostick

Device

Primary outcomes

  1. Newly detected AF

    Time frame: during influenza vaccination

Sponsors and collaborators

Lead sponsor

UMC Utrecht

Other

Collaborators

  • Boehringer Ingelheim

Registry information

Important dates

Study start
2013
Primary completion
2014
Study completion
2014
First posted
Dec 10, 2013
Registry last updated
May 12, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.